Literature DB >> 34482472

Indolent T-lymphoblastic proliferation: a report of three cases.

Zheng Yuanyuan1, Xie Jianlan1, Zhang Yanlin1, Zhou Xiaoge2.   

Abstract

Indolent T-lymphoblastic proliferation (iT-LBP) is the extrathymic proliferation of nonclonal TdT + T cells and is typically associated with lymphoid disorders. Although one study revealed that iT-LBP occurred in angioimmunoblastic T-cell lymphoma, no other lymphoma-related cases have been reported. Here, we report three cases of concurrent iT-LBP and benign or malignant lymphoid disorders. The first patient had bilateral cervical lymph node enlargement, and the resected lymph node showed polyclonal precursor T-cells distributed between benign hyperplastic lymphoid follicles. In the second case, iT-LBP occurred in peripheral T-cell lymphoma with a follicular growth pattern, showing that precursor T-cells were distributed between neoplastic follicles composed of CD4 + and CXCL13 + T-cells. In the third case, polyclonal precursor T-cells were distributed between the neoplastic follicles of follicular lymphoma. In summary, our results indicate an association between iT-LBP and reactive lymphoid hyperplasia (case 1) and lymphoma (cases 2 and 3).
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Angioimmunoblastic T-cell lymphoma; Benign and nonclonal hyperplasia; Indolent T-lymphoblastic proliferation; Lymphoma

Mesh:

Year:  2021        PMID: 34482472     DOI: 10.1007/s00428-021-03184-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy.

Authors:  M M Velankar; B N Nathwani; M J Schlutz; L A Bain; D A Arber; M L Slovak; L M Weiss
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

2.  Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy.

Authors:  You-Wen Qian; David Weissmann; Lauri Goodell; David August; Roger Strair
Journal:  Leuk Lymphoma       Date:  2009-02

3.  Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.

Authors:  Robert S Ohgami; Anoop K Sendamarai; Susan K Atwater; Michaela Liedtke; Mark D Fleming; Yasodha Natkunam; Roger A Warnke
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

4.  Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease.

Authors:  Andrés E Quesada; Ken H Young; L Jeffrey Medeiros; Beenu Thakral
Journal:  Pathology       Date:  2018-03-02       Impact factor: 5.306

5.  [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: A case report].

Authors:  Bertrand Chauveau; François Le Loarer; Julia Bacci; François Baylac; Pierre Dubus; Catherine Ling; Marie Parrens
Journal:  Ann Pathol       Date:  2018-12-13       Impact factor: 0.407

6.  Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.

Authors:  Rina Kansal; Bharat N Nathwani; Xanthi Yiakoumis; Maria Moschogiannis; Sotirios Sachanas; Kalliopi Stefanaki; Gerassimos A Pangalis
Journal:  Hum Pathol       Date:  2015-03-26       Impact factor: 3.466

7.  TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.

Authors:  Robert S Ohgami; Shuchun Zhao; Jane K Ohgami; Matthew O Leavitt; James L Zehnder; Robert B West; Daniel A Arber; Yasodha Natkunam; Roger A Warnke
Journal:  Am J Surg Pathol       Date:  2012-11       Impact factor: 6.394

Review 8.  Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.

Authors:  Robert S Ohgami; Daniel A Arber; James L Zehnder; Yasodha Natkunam; Roger A Warnke
Journal:  Adv Anat Pathol       Date:  2013-05       Impact factor: 3.875

9.  Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome.

Authors:  Matthew Walters; Mark R Pittelkow; Robert P Hasserjian; Nancy Lee Harris; William R Macon; Paul J Kurtin; Karen L G Rech
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

10.  TdT+ T-Lymphoblastic Proliferation in Castleman Disease.

Authors:  Chang Gok Woo; Jooryung Huh
Journal:  J Pathol Transl Med       Date:  2015-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.